GlaxoSmithKline PLC ADR (GSK) stock chart and technical analysis

Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-09-18, the close was $50.22: 1.2% below the 50-day average and 2.6% below the 200-day average, which is rising. RSI (14) is 49, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 55% of the way up its 52-week range of $37.93 to $60.09, on 1.7x its 20-day average volume.

Indicator	Reading	Read
50-day average	$50.84	Price 1.2% below
200-day average	$51.59	Price 2.6% below, average rising
50 vs 200-day	50 below 200	Death-cross alignment
RSI (14)	49	Neutral range
MACD (12, 26, 9)	-0.29 vs -0.41	Bullish cross in the last 10 days
52-week range	$37.93 to $60.09	55% of the way up the range
Volume vs 20-day average	1.7x	Heavy

What followed this setup for GSK

When it closed below its 200-day average (2,445 days), it was higher 63 trading days later 61% of the time, median +2.4%.
When it closed below its 50-day average (2,860 days), it was higher 63 trading days later 61% of the time, median +2.4%.
When it had MACD above its signal line (3,316 days), it was higher 63 trading days later 58% of the time, median +1.5%.
All days since 1999 (6,698 days): higher 63 trading days later 58% of the time, median +1.4%.

Base rates use GSK's own daily history since 1999; they describe the past, not a forecast.

ŷRobot chart signal: Buy, from the chart signal model.

GSK analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks

ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.